Cite

HARVARD Citation

    Paksoy, N. et al. (2022). Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report. Journal of oncology pharmacy practice. pp. 215-221. [Online]. 
  
Back to record